SSZ could inhibit CD44v9-positive CCA cell proliferation and stimulate CCA cell death via a reduction of glutathione (GSH), consequently increasing intracellular ROS levels and inducing the phosphorylation of p38 mitogen-activated protein kinase, an indicator of intracellular ROS levels [15]. Here, MAPK14 is linked to cholangiocarcinoma.